Concepedia

C.-R. Yu

CY

Statistics

Publications

4

Citations

252

H-Index

4

Active since

2012

Affiliations

Pfizer (United States)(Current)

Penn State Milton S. Hershey Medical Center

C.-R. Yu is an author at Pfizer (United States) specializing in pharmacotherapy, pharmacology, and pharmacotherapy for nicotine dependence.

Publications per year

2012–2016

4

Publications

4

The Fagerstrom Test for Nicotine Dependence as a Predictor of Smoking Abstinence: A Pooled Analysis of Varenicline Clinical Trial Data

K. Fagerström, Cristina Russ, C.-R. Yu et al. · Nicotine & Tobacco Research · 2012 · 170 citations

Public Health, Pharmacology, Pharmacotherapy +17

Effect of Varenicline on Individual Nicotine Withdrawal Symptoms: A Combined Analysis of Eight Randomized, Placebo-Controlled Trials

Jonathan Foulds, Cristina Russ, C.-R. Yu et al. · Nicotine & Tobacco Research · 2013 · 48 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials

John C. Gallagher, Santiago Palacios, Kelly A. Ryan et al. · Menopause The Journal of The North American Menopause Society · 2016 · 21 citations

Pharmacy, Endocrinology, Pharmacotherapy +17

The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis

Thomas Beck, Thomas Fuerst, Kenneth W. Gaither et al. · Bone · 2015 · 13 citations

Medicine, Orthopedic Surgery, Pharmacology +13

1–4 of 4